Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease.
Ontology highlight
ABSTRACT: In the last decades, the global prevalence of non-alcoholic fatty liver disease (NAFLD) has reached pandemic proportions with derived major health and socioeconomic consequences; this tendency is expected to be further aggravated in the coming years. Obesity, insulin resistance/type 2 diabetes mellitus, sedentary lifestyle, increased caloric intake and genetic predisposition constitute the main risk factors associated with the development and progression of the disease. Importantly, the interaction between the inherited genetic background and some unhealthy dietary patterns has been postulated to have an essential role in the pathogenesis of NAFLD. Weight loss through lifestyle modifications is considered the cornerstone of the treatment for NAFLD and the inter-individual variability in th
SUBMITTER: Martinez-Montoro JI
PROVIDER: S-EPMC8625016 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA